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prevalence of VVS among Saudi medical students and to deter-
mine the effect of family history on the likelihood of predicting.
Methods and results: We surveyed medical students at King
Saud Medical School and their ﬁrst-degree relatives for VVS.
Ascertainment of VVS syncope was with the Calgary syncope
score. Sixty-two medical students and 200 ﬁrst-degree relatives
were studied. The prevalence of VVS was 4.5%, the mean age of
the cohort was 22.1 ± 1.5, and the median age of the ﬁrst faint
in those who fainted was 17 years. More females than male fainted
(7.7% vs. 3.2%; p= 0.01). Females with two fainting parents were
more likely to faint than those with no fainting parents (65.5% vs.
34.5%; p< 0.0001). Females with fainting mother were more
likely to faint than those with no fainting mother (55.2% vs.
41.4%; p= 0.001).
Conclusion: Family history of both parents fainting and the
mother fainting are important predictors of vasovagal syncope.
Subject: Does ‘‘EuroScore model’’ predict mortality in surgery
for infective endocarditis?
doi:10.1016/j.jsha.2011.02.107
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Objective: We sought to test the applicability of the ‘‘European
System for Cardiac Operative Risk Evaluation’’ (EuroSCORE) in
patients with Infective Endocarditis (IE).
Methods: We retrospectively analyzed a prospectively collected
data of 64 consecutive patients operated for IE in our institution
between 1999 and 2009. We compared the actual in-hospital mor-
tality and the predicted morality using ‘‘EuroScore’’. Urgent sur-
gery was performed in 58 patients (91%). Thirty-eight patients
(60%) underwent aortic valve surgery, of which 14 patients
(22%) underwent concomitant mitral valve surgery and 5 patients
(8%) had also tricuspid valve surgery. Isolated mitral valve
replacement/repair was performed in 17 patients (27%) and with
tricuspid surgery in 3 patients (5%). Pulmonary valve surgery
was performed in 2 patients (3%).
The total clamp time 132.4 ± 63 min. Cross clamp time
92.7 ± 47.5 min. Preoperative sepsis was documented in 44
(68%) patients. Cerebro-vascular events were documented in 10
(16%) patients within 4 weeks before surgery. Preoperative left
ventricular function (LVEF) (50 ± 22.6), and the right ventricular
systolic pressure (RVSP) (52 ± 10.4) mm Hg. Intra-operative
IABP was used in 5 patients.
Results: The predicted mortality was 10.74%± 10.78, mean
additive EuroSCORE was 6.51 ± 3. The actual mortality was 5
patients (8%). The EuroSCORE for the deceased patients was
11, 5, 8, 5 and 14.
Conclusion: Our data have shown that EuroSCORE has low
discrimination ability to predict mortality in IE surgery. Further
studies with a larger sample size are required to further validate
the application of EuroScore in our population.
doi:10.1016/j.jsha.2011.02.108
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Background: The aim of the present study is to focus on the
therapeutic potential of low molecular weight Fucoidan (LMWF)
in a rat model of myocardial ischemia–reperfusion injury.
Methods: Forty rats were submitted to myocardial ischemia–
reperfusion injury by transient occlusion of the left coronary ar-
tery. Rats were then randomized into two groups: Fucoidan
groups, LMWF (5 mg/kg, in 0.5 ml saline intramuscularly;
n= 20) was administered 1 h before injury and daily thereafter
for 1 month or control groups (saline alone; n= 20). At 1 month
before sacriﬁcing rats, blood levels of stromal-cell derived factor-
1f (SDF-1) were assessed by ELISA. Also, hearts were evaluated
by histo-immunochemistry in ischemic area.
Results: Fucoidan treatment had signiﬁcant anti-ﬁbrotic
effects, reducing the infarct scar size by almost 30% on Sirius
red-stained sections (9.45 ± 4.27% vs 13 ± 5.67% in controls;
p= 0.03). Vascular density (Actin, RECA-1 or lectin-BS1 stained)
was increased by 40% (2.18 ± 0.79 vs 1.49 ± 0.42 mm2 (200·) in
controls, p= 0.001). Plasma SDF-1 was not signiﬁcantly different
in treated versus control groups. Increased immunostaining of
SDF-1f and vascular endothelial growth factor in ﬁbrotic ischemic
tissues was observed in treated rats compared to controls.
Conclusion: LMWF enhanced tissue repair in myocardial ische-
mia–reperfusion by promoting revascularization and limiting
ﬁbrosis. Consequently, Fucoidan may have potential therapeutic
use in acute ischemic diseases.
doi:10.1016/j.jsha.2011.02.109
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We report a case of surgically retained pericardial sponge
(abdominal pad) as a cause of posterior pericardial mass and peri-
cardio-cutaneous ﬁstula. In a woman who had coronary artery by-
pass grafting 3 years before presenting to the hospital for removal
of the sponge. The radio opaque material was seen on the plane
CXR and the exact location of the lost pad has been identiﬁed
by using CT scan images and Ba swallow procedures. The pad
was removed surgically without complications.
doi:10.1016/j.jsha.2011.02.110
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Background: The PAS-Port (Cardica Inc., Redwood City, CA)
is an automated system that allows for the clampless anastomosis
of vein grafts to the aorta. The aim of this study was to compare
early results of this system with conventional hand-sewn anasto-
moses in patients underwent elective coronary bypass surgery.
Methods: A total of 20 patients undergoing elective on pump
coronary bypass surgery receive proximal anastomosis with
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hand-sewn conventional technique and at least one anastomosis
with the PAS-Port system. Patient follow-up consisted of multi-
slice computed tomographic scans or coronary angiogram per-
formed at discharge and 6 months postoperatively.
Results: Twenty-seven proximal anastomosis was performed
using PAS-Port and 15 anastomosis done using hand-sewn tech-
nique. In two patients severe atherosclerosis of the aorta required
to do all proximal anastomosis using the PAS-Port device. All the
Pas-Port anastomosis were done successfully. Time needed for
completion of the proximal anastomosis including graft loading
was 152 ± 19 s for the PAS-Port. No mortality or stroke seen
early or at fellow-up. Patency at discharge was 100% in both
PAS-Port and hand-sewn group and after 6 months.
Conclusions: This study demonstrated excellent short and mid-
term patency in both the hand-sewn and PAS-Port grafts. The
PAS-Port system allowed for the rapid, safe, and effective creation
of a proximal anastomosis without the need to clamp the aorta.
Based on this study we consider this product a valid alternative
for proximal anastomosis, especially in patients with severe aortic
disease, to avoid side clamping of the aorta.
doi:10.1016/j.jsha.2011.02.111
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Incidence of human transplanted skeletal myoblast (SkM) cell
death in ischemic myocardium was higher after cell therapy. We
proposed that human SkM treated by human stromal cell-derived
factor (SDF-1 protein or transfected by SDF-1, precondition them
against oxidative or anoxic injury. The puriﬁcation of human SkM
(80–90%) culture was assessed for desmin and CXCR4 expression.
Cells were transfected to overexpress SDF-1f or treated with
rSDF-1 (10–200 ng/ml, 1–4 h) were either exposed to anoxia or
treated with 100 lM H2O2 for different time periods (1–6 h anox-
ia) (1–3 h H2O2). Optimized conditions for transfection of SDF-1
gene into human SkM were achieved, using FuGeneTM6/phSDF-
1 (3:2 v/w, 4 h transfection) with 125 lM ZnCl2 (p< 0.001), up to
7 days post-transfection as compared with transfected SkM with-
out ZnCl2 and non-transfected control cells. Transfection efﬁ-
ciency was assessed by immunostaining, ELISA, Western blots
and PCR. LDH analysis showed signiﬁcant decrease in release
of LDH after exposure to 6 h anoxia or 100 lM H2O2 for 2 h as
compared with the normal un-treated or untransfected SkM
(p< 0.001). In Western-blots assay, SDF-1 over-expressing hu-
man SkM or treated with rSDF-1 induced marked expression of
total Akt (1.2-fold) and phospho-Akt (2.7-fold), Bcl2 (1.6-fold)
and VEGF (5.8-fold) after exposure to 6 h anoxia as compared
with human SkM controls. SDF-1 transgene delivery of human
SkM induced signal transduction that increased cell survival and
release of VEGF that promoted cytoprotective effect against oxi-
dative or anoxic injury. The preconditioning of donor trans-
planted human SkM with SDF-1 may be an innovative
approach for clinical application.
doi:10.1016/j.jsha.2011.02.113
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Objective: Is to compare the inﬂuence of the internal thoracic
artery (ITA) harvesting technique on longterm outcome after OP-
CAB surgery.
Methods: 1250 consecutive patients underwent OPCAB be-
tween 1996 and 2006 at our institute. From September 1996 to
January 2000 patients ITAs were pedicled (PD) (n= 442), and
from February 2000 till May 2006 the ITAs were skeletonized
(SK) (n= 805). Three patients did not receive ITA graft. Overall
survival and occurrence of MACE were prospectively documented
for both groups. MACE were deﬁned as rehospitalization for
myocardial infarction, unstable angina, congestive heart failure,
new revascularization either percutaneous or surgical, and sudden
or cardiac death. Mean follow-up time was 66 ± 22 months and
was completed in 97% of the patients.
Results: SK-patients were older (p= 0.01), had a lower left
ventricular ejection (p= 0.009), and a higher prevalence of diabe-
tes, high blood pressure, obesity, pulmonary artery hypertension,
and recent MI. Number of distal anastomoses were higher in
SK-patients (p= 0.0001). A trend toward a lower prevalence of
wound infection in diabetic SK-patients with bilateral ITA har-
vesting (1.2% vs 4.6%) was observed. There were no differences
in operative and long-term overall mortality between both groups.
MACE-free survival at 1, 3 and 5 years were 96 ± 1%, 91 ± 1%,
86 ± 2% in SK-patients and 95 ± 1%, 91 ± 1.5%, 88 ± 2% in
PD patients (p= .87).
Conclusions: Even though SK patients were older and pre-
sented more preoperative comorbidities, they had a long-term out-
come comparable to PD-SK patients. Our results conﬁrm the
safety and efﬁciency of ITA skeletonization in OPCAB surgery.
doi:10.1016/j.jsha.2011.02.114
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